Masters Capital Management’s Gilead Sciences GILD Stock Holding History

Masters Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-600,000	Closed	-$41.3M	–	71
2021 Q3	$41.9M	Sell	600,000 -400,000	-40%	-$28.1M	1.73%	16
2021 Q2	$68.9M	Hold	1,000,000	–	–	2.03%	12
2021 Q1	$64.6M	Buy	+1,000,000	New	+$64.5M	2.16%	10
2019 Q2	–	Sell	-300,000	Closed	-$19.5M	–	69
2019 Q1	$19.5M	Buy	+300,000	New	+$19.9M	1.04%	28
2018 Q4	–	Sell	-100,000	Closed	-$7.72M	–	67
2018 Q3	$7.72M	Sell	100,000 -283,780	-74%	-$21.4M	0.19%	67
2018 Q2	$27.2M	Buy	383,780 +183,780	+92%	+$13M	0.77%	37
2018 Q1	$15.1M	Sell	200,000 -100,000	-33%	-$7.95M	0.33%	52
2017 Q4	$21.5M	Buy	+300,000	New	+$22.8M	0.51%	45
2017 Q2	–	Sell	-500,000	Closed	-$33.3M	–	73
2017 Q1	$34M	Sell	500,000 -100,000	-17%	-$7.03M	0.84%	35
2016 Q4	$43M	Buy	+600,000	New	+$44.6M	0.94%	28

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Masters Capital Management's GILD Position: Q4 2021 in Review

Masters Capital Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 600,000 shares — an estimated $41.3M sold.

Masters Capital Management first reported a position in GILD in Q4 2016 and held it in 10 quarters. The position peaked at $68.9M in Q2 2021. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

Masters Capital Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
Masters Capital Management sold 600,000 Gilead Sciences shares in Q4 2021, an estimated $41.3M.
Masters Capital Management first reported a position in Gilead Sciences in Q4 2016 and held it in 10 quarters.
Masters Capital Management's Gilead Sciences position peaked at $68.9M in Q2 2021.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Masters Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.